Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Chua, GN"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2014, Iss default, Pp 473-481 (2014)
Asrul Akmal Shafie, Yen Wei Lim, Gin Nie Chua, Mohammed Azmi Ahmad Hassali Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains, Penang, Malaysia Introduction: The incremental cost-effectiveness ratio
Externí odkaz:
https://doaj.org/article/dde4bab4beda44e1aaa1a6c22b3eedd5
Publikováno v:
In Value in Health June 2024 27(6) Supplement:S340-S340
Publikováno v:
In Value in Health November 2016 19(7):A827-A827
Autor:
Heidenreich S; Patient Centered Research, Evidera, London, UK., Ross M; Patient Centered Research, Evidera, Bethesda, MD, USA., Chua GN; Patient Centered Research, Evidera, London, UK., Seboek Kinter D; Idorsia, Allschwil, Switzerland., Phillips-Beyer A; Innovus Consulting, London, UK.
Publikováno v:
Sleep [Sleep] 2022 Nov 09; Vol. 45 (11).
Autor:
Hubig LT; Acaster Lloyd Consulting Ltd, London, UK., Smith T; StudyMetrix LLC, St. Peters, Missouri, USA., Chua GN; Acaster Lloyd Consulting Ltd, London, UK., Lloyd AJ; Acaster Lloyd Consulting Ltd, London, UK., Powell L; Broadstreet HEOR, Vancouver, British Columbia, Canada., Johnston K; Broadstreet HEOR, Vancouver, British Columbia, Canada., Harris L; Biohaven Pharmaceuticals Inc, New Haven, Connecticut, USA., L'Italien G; Biohaven Pharmaceuticals Inc, New Haven, Connecticut, USA., Coric V; Biohaven Pharmaceuticals Inc, New Haven, Connecticut, USA., Lo SH; Acaster Lloyd Consulting Ltd, London, UK.
Publikováno v:
Headache [Headache] 2022 Oct; Vol. 62 (9), pp. 1187-1197. Date of Electronic Publication: 2022 Sep 01.
Autor:
Heidenreich S; Evidera, London, UK., Finney Rutten LJ; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Miller-Wilson LA; Exact Sciences Corporation, Madison, Wisconsin, USA., Jimenez-Moreno C; Evidera, London, UK., Chua GN; Evidera, London, UK., Fisher DA; Duke Clinical Research Institute, Durham, North Carolina, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2022 Aug; Vol. 11 (16), pp. 3156-3167. Date of Electronic Publication: 2022 Mar 21.
Autor:
Chua GN; Health Economics Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK. ginniechua@gmail.com., Bond C; Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK., Porteous T; Centre for Healthcare Education Research and Innovation, Institute of Education for Medical and Dental Sciences, and Health Economics Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK., Ryan M; Health Economics Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Publikováno v:
The patient [Patient] 2022 Jul; Vol. 15 (4), pp. 473-483. Date of Electronic Publication: 2022 Jan 24.
Autor:
Tervonen T; Evidera, The Ark, 201 Talgarth Rd, London W6 8BJ, UK; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: tommi.tervonen@evidera.com., Prawitz T; Evidera, The Ark, 201 Talgarth Rd, London W6 8BJ, UK., Chua GN; Evidera, The Ark, 201 Talgarth Rd, London W6 8BJ, UK., Hyacinthe J; Department of Epidemiology, Merck & Co., Inc., Kenilworth, NJ, USA., Pinto CA; Department of Epidemiology, Merck & Co., Inc., Kenilworth, NJ, USA.
Publikováno v:
Journal of clinical epidemiology [J Clin Epidemiol] 2022 Apr; Vol. 144, pp. 84-92. Date of Electronic Publication: 2021 Nov 29.
Autor:
Pinto CA; Merck & Co., Inc., Kenilworth, NJ, USA., Chua GN; Evidera, London, UK., Bridges JFP; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH, USA., Brookes E; Evidera, London, UK., Hyacinthe J; Merck & Co., Inc., Kenilworth, NJ, USA., Tervonen T; Evidera, London, UK. tommi.tervonen@evidera.com.; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. tommi.tervonen@evidera.com.
Publikováno v:
The patient [Patient] 2022 Mar; Vol. 15 (2), pp. 255-266. Date of Electronic Publication: 2021 Sep 27.
Autor:
Gelhorn H; Evidera, Bethesda, MD 20814, USA., Garris C; US Health Outcomes, ViiV Healthcare, Research Triangle Park, NC 27709, USA., Arthurs E; GlaxoSmithKline, Mississauga, ON L5N 6L4, Canada., Spinelli F; North American Medical Affairs, ViiV Healthcare, Research Triangle Park, NC 27709, USA., Cutts K; Evidera, Bethesda, MD 20814, USA., Chua GN; Evidera, London W6 8BJ, UK., Collacott H; Evidera, London W6 8BJ, UK., Lebouché B; Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC H3H 2R9, Canada.; Chronic Viral Illness Service, Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.; Department of Family Medicine, Faculty of Medicine, McGill University, Montreal, QC H3S 1Z1, Canada., Lowman E; Midland Medical Center, Oakland Park, FL 33334, USA., Rice H; Rice Medical Group, Mountain View, CA 94040, USA., Heidenreich S; Evidera, London W6 8BJ, UK.
Publikováno v:
Journal of personalized medicine [J Pers Med] 2022 Feb 23; Vol. 12 (3). Date of Electronic Publication: 2022 Feb 23.